These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 32981815)

  • 1. YAP and TAZ Are Not Identical Twins.
    Reggiani F; Gobbi G; Ciarrocchi A; Sancisi V
    Trends Biochem Sci; 2021 Feb; 46(2):154-168. PubMed ID: 32981815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms.
    Dobrokhotov O; Samsonov M; Sokabe M; Hirata H
    Clin Transl Med; 2018 Aug; 7(1):23. PubMed ID: 30101371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Hippo pathway effector proteins YAP and TAZ have both distinct and overlapping functions in the cell.
    Plouffe SW; Lin KC; Moore JL; Tan FE; Ma S; Ye Z; Qiu Y; Ren B; Guan KL
    J Biol Chem; 2018 Jul; 293(28):11230-11240. PubMed ID: 29802201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The YAP/TAZ Pathway in Osteogenesis and Bone Sarcoma Pathogenesis.
    Kovar H; Bierbaumer L; Radic-Sarikas B
    Cells; 2020 Apr; 9(4):. PubMed ID: 32326412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. YAP and TAZ differentially regulate postnatal cortical progenitor proliferation and astrocyte differentiation.
    Chen J; Tsai YH; Linden AK; Kessler JA; Peng CY
    J Cell Sci; 2024 May; 137(10):. PubMed ID: 38639242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YAP and TAZ Negatively Regulate Prox1 During Developmental and Pathologic Lymphangiogenesis.
    Cho H; Kim J; Ahn JH; Hong YK; Mäkinen T; Lim DS; Koh GY
    Circ Res; 2019 Jan; 124(2):225-242. PubMed ID: 30582452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hippo pathway inhibition by blocking the YAP/TAZ-TEAD interface: a patent review.
    Crawford JJ; Bronner SM; Zbieg JR
    Expert Opin Ther Pat; 2018 Dec; 28(12):867-873. PubMed ID: 30482112
    [No Abstract]   [Full Text] [Related]  

  • 8. Multifaceted regulation and functions of YAP/TAZ in tumors (Review).
    Liu H; Du S; Lei T; Wang H; He X; Tong R; Wang Y
    Oncol Rep; 2018 Jul; 40(1):16-28. PubMed ID: 29749524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A YAP/TAZ-TEAD signalling module links endothelial nutrient acquisition to angiogenic growth.
    Ong YT; Andrade J; Armbruster M; Shi C; Castro M; Costa ASH; Sugino T; Eelen G; Zimmermann B; Wilhelm K; Lim J; Watanabe S; Guenther S; Schneider A; Zanconato F; Kaulich M; Pan D; Braun T; Gerhardt H; Efeyan A; Carmeliet P; Piccolo S; Grosso AR; Potente M
    Nat Metab; 2022 Jun; 4(6):672-682. PubMed ID: 35726026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. YAP/TAZ for cancer therapy: opportunities and challenges (review).
    Guo L; Teng L
    Int J Oncol; 2015 Apr; 46(4):1444-52. PubMed ID: 25652178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Hippo Signaling Improves Skin Lesions in a Rosacea-Like Mouse Model.
    Lee J; Jung Y; Jeong SW; Jeong GH; Moon GT; Kim M
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33477764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Hippo signaling pathway provides novel anti-cancer drug targets.
    Bae JS; Kim SM; Lee H
    Oncotarget; 2017 Feb; 8(9):16084-16098. PubMed ID: 28035075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinctive Roles of YAP and TAZ in Human Endothelial Progenitor Cells Growth and Functions.
    Klaihmon P; Lorthongpanich C; Kheolamai P; Luanpitpong S; Issaragrisil S
    Biomedicines; 2022 Jan; 10(1):. PubMed ID: 35052826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TAZ target gene ITGAV regulates invasion and feeds back positively on YAP and TAZ in liver cancer cells.
    Weiler SME; Lutz T; Bissinger M; Sticht C; Knaub M; Gretz N; Schirmacher P; Breuhahn K
    Cancer Lett; 2020 Mar; 473():164-175. PubMed ID: 31904487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large tumor suppressor homologs 1 and 2 regulate mouse liver progenitor cell proliferation and maturation through antagonism of the coactivators YAP and TAZ.
    Yi J; Lu L; Yanger K; Wang W; Sohn BH; Stanger BZ; Zhang M; Martin JF; Ajani JA; Chen J; Lee JS; Song S; Johnson RL
    Hepatology; 2016 Nov; 64(5):1757-1772. PubMed ID: 27531557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vestigial-like family member 3 (VGLL3), a cofactor for TEAD transcription factors, promotes cancer cell proliferation by activating the Hippo pathway.
    Hori N; Okada K; Takakura Y; Takano H; Yamaguchi N; Yamaguchi N
    J Biol Chem; 2020 Jun; 295(26):8798-8807. PubMed ID: 32385107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA binding partners of YAP/TAZ.
    Kim MK; Jang JW; Bae SC
    BMB Rep; 2018 Mar; 51(3):126-133. PubMed ID: 29366442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Hippo Pathway Effectors YAP/TAZ-TEAD Oncoproteins as Emerging Therapeutic Targets in the Tumor Microenvironment.
    Mokhtari RB; Ashayeri N; Baghaie L; Sambi M; Satari K; Baluch N; Bosykh DA; Szewczuk MR; Chakraborty S
    Cancers (Basel); 2023 Jul; 15(13):. PubMed ID: 37444578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional co-repressor function of the hippo pathway transducers YAP and TAZ.
    Kim M; Kim T; Johnson RL; Lim DS
    Cell Rep; 2015 Apr; 11(2):270-82. PubMed ID: 25843714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative Real-Time PCR to Measure YAP/TAZ Activity in Human Cells.
    Cao X; Zhao B
    Methods Mol Biol; 2019; 1893():137-152. PubMed ID: 30565132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.